83 related articles for article (PubMed ID: 12646195)
21. Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.
Goukassian D; Sanz-González SM; Pérez-Roger I; Font de Mora J; Ureña J; Andrés V
Br J Pharmacol; 2001 Apr; 132(7):1597-605. PubMed ID: 11264255
[TBL] [Abstract][Full Text] [Related]
22. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ
Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
24. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells.
Morita T; Mitsialis SA; Koike H; Liu Y; Kourembanas S
J Biol Chem; 1997 Dec; 272(52):32804-9. PubMed ID: 9407056
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of AKT activation by E2F.
Chaussepied M; Ginsberg D
Mol Cell; 2004 Dec; 16(5):831-7. PubMed ID: 15574337
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
27. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
Lee HY; Dohi DF; Kim YH; Walsh GL; Consoli U; Andreeff M; Dawson MI; Hong WK; Kurie JM
J Clin Invest; 1998 Mar; 101(5):1012-9. PubMed ID: 9486971
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional squelching by ectopic expression of E2F-1 and p53 is alleviated by proteasome inhibitors MG-132 and lactacystin.
Magae J; Illenye S; Tejima T; Chang YC; Mitsui Y; Tanaka K; Omura S; Heintz NH
Oncogene; 1997 Aug; 15(7):759-69. PubMed ID: 9266962
[TBL] [Abstract][Full Text] [Related]
29. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
30. Mcm7, a subunit of the presumptive MCM helicase, modulates its own expression in conjunction with Mcm1.
Fitch MJ; Donato JJ; Tye BK
J Biol Chem; 2003 Jul; 278(28):25408-16. PubMed ID: 12738768
[TBL] [Abstract][Full Text] [Related]
31. The interaction between ATRIP and MCM complex is essential for ATRIP chromatin loading and its phosphorylation in mantle cell lymphoma cells.
Nie Y; Lang T
Pharmazie; 2017 Nov; 72(11):670-673. PubMed ID: 29442041
[TBL] [Abstract][Full Text] [Related]
32. Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors.
Fujita N; Furukawa Y; Du J; Itabashi N; Fujisawa G; Okada K; Saito T; Ishibashi S
Mol Cell Endocrinol; 2002 Jun; 192(1-2):75-84. PubMed ID: 12088869
[TBL] [Abstract][Full Text] [Related]
33. EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.
Novy M; Pohn R; Andorfer P; Novy-Weiland T; Galos B; Schwarzmayr L; Rotheneder H
Mol Biol Cell; 2005 May; 16(5):2181-90. PubMed ID: 15716352
[TBL] [Abstract][Full Text] [Related]
34. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
Tomita N; Kim JY; Gibbons GH; Zhang L; Kaneda Y; Stahl RA; Ogborn M; Venderville B; Morishita R; Baran D; Dzau VJ
Int J Mol Med; 2004 May; 13(5):629-36. PubMed ID: 15067361
[TBL] [Abstract][Full Text] [Related]
36. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of E2F-4/DP-1-stimulated transcription by p202.
Choubey D; Gutterman JU
Oncogene; 1997 Jul; 15(3):291-301. PubMed ID: 9233764
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties.
Zohlnhöfer D; Nührenberg TG; Neumann FJ; Richter T; May AE; Schmidt R; Denker K; Clauss MA; Schömig A; Baeuerle PA
Mol Pharmacol; 2004 Apr; 65(4):880-9. PubMed ID: 15044617
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication.
Kudoh A; Daikoku T; Ishimi Y; Kawaguchi Y; Shirata N; Iwahori S; Isomura H; Tsurumi T
J Virol; 2006 Oct; 80(20):10064-72. PubMed ID: 17005684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
